--- title: CMC Analytical Development CDMOs in China path: /services/cmc-analytical-development/china companies_count: 18 --- # CMC Analytical Development CDMOs in China 18 published CDMOs match CMC Analytical Development in China. Locations in this set include China, United States, France, Singapore, Switzerland, and Italy. Capabilities that show up most often in this set: Biologics (Monoclonal Antibodies), Biologics (Other), Antibody-Drug Conjugate (ADC), Small Molecule, and Peptide. ## Matching companies - [Altruist Biologics](/companies/altruist-biologics) - Global CDMO offering end-to-end development and GMP manufacturing for monoclonal antibodies, bispecific antibodies, fusion proteins, recombinant proteins, and antibody-drug conjugates, with facilities in Suzhou and Hangzhou featuring up to 20,000-liter bioreactors. - [Boston Institute of Biotechnology, LLC](/companies/bostonbib) - Full-service CDMO offering cGMP and non-GMP mammalian, microbial, gene therapy, and cell therapy manufacturing from preclinical to commercial scale, with bioreactor capacity up to 50,000L. - [Carbogen Amcis](/companies/carbogen-amcis) - Full-service CDMO offering integrated drug substance and sterile drug product development and manufacturing from early phase through commercialization, with specialized capabilities in API synthesis, process development, analytical services, and stability testing across multiple scales. - [Catalent](/companies/catalent) - Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply. - [Dipharma](/companies/dipharma) - Global CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970. - [Flamma](/companies/flammagroup) - Privately held small molecule CDMO with FDA-inspected cGMP facilities in Italy, USA, and China, offering custom manufacturing, development, and specialized technologies including HPAPI, continuous flow, and cryogenic API synthesis from early-stage to commercial scale. - [JYMed Peptide](/companies/jymedtech) - Peptide CDMO offering custom synthesis from milligrams to metric tons, with 13 cGMP lines and FDA-, NMPA- and EDQM-approved sites. Provides peptide API manufacturing plus syringe, cartridge and lyophilized finished-dose filling at its Shenzhen site. - [PharmaBlock](/companies/pharmablock) - Leading provider of innovative chemistry products and services for pharmaceutical R&D and commercial manufacturing, with expertise in process development, GMP manufacturing, and low-carbon chemistry solutions. - [Pharmaron](/companies/pharmaron) - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK. - [Piramal Pharma Solutions](/companies/piramalpharmasolutions) - CDMO specializing in HPAPIs, ADCs, peptides, vaccines, and biologics with 4,700+ team members across 15 global sites and 500+ customers. Offers integrated development and manufacturing with backward integration capabilities and global program management. - [Porton](/companies/portonpharma) - Porton is a global CDMO offering integrated manufacturing and development services across small molecules, peptides, oligonucleotides, biologics, and conjugates with specialized capabilities in flow chemistry, biocatalysis, and advanced therapies. - [Porton Advanced](/companies/porton-advanced) - End-to-end ATMP CDMO provider offering cell engineering, lentiviral vectors, mRNA/LNP, plasmid development, and GMP manufacturing from preclinical through commercialization with 24 IND approvals across NMPA, FDA, and MedSafe. - [Roquette Pharma Solutions](/companies/roquette) - Roquette is a leading global provider of plant-based ingredients, excipients, and solutions for the pharmaceutical and healthcare industries. - [Stevanato Group](/companies/stevanatogroup) - Leading global provider of integrated drug containment, drug delivery, and diagnostic solutions with 75+ years' experience in glass primary packaging, contract manufacturing, and analytical services across development, clinical, and commercial stages. - [Unither Pharmaceuticals](/companies/unither-pharma) - Global CDMO specializing in sterile and non-sterile liquid manufacturing, including Blow-Fill-Seal (BFS) single-dose technology with over 5 billion annual capacity, plus formulation development, analytical services, and ophthalmic expertise across six production sites. - [Vetter Pharma](/companies/vetter-pharma) - Independent CDMO specialist in aseptic fill-finish, drug product development, analytical services, and combination product assembly with 76 years of experience and 7,300+ employees globally. - [WuXi Vaccines](/companies/wuxivaccines) - Global CDMO specializing in end-to-end vaccine and prophylactic antibody development and manufacturing across mammalian, viral, and microbial platforms with GMP-certified facilities and over 550 million doses delivered. - [WuXi XDC](/companies/wuxi-xdc) - WuXi XDC is a leading CRDMO offering integrated discovery, development, and cGMP manufacturing services for antibody drug conjugates (ADCs) and bioconjugates, with proximately located facilities that reduce development timelines and costs.